• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Pharmaceutical Conference in Shanghai to Showcase China's R&D Outsourcing and Partnership Opportunities for Multinational Pharma & Biotech Companies

Posted on: Monday, 2 April 2007, 12:00 CDT

Over the past few years, the strategic importance of China to the global pharmaceutical marketplace has become increasingly clearer. Multinational interest and investment in China's pharmaceutical industry is at an all-time high and competition is heating up. Companies are looking to China not only for outsourcing opportunities anymore, they are setting up major R&D facilities and striking licensing and partnership deals with local Chinese biotechs. But what strategies are working best? What companies are best positioned to benefit from China's economic growth?

"IMPACT CHINA III: Pharmaceutical R&D Global Summit," taking place May 20-23, 2007 in Shanghai, China is the industry's leading pharmaceutical event on the emergence of China, organized by ALM's Strategic Research Institute based in New York and is designed to bring together pharma and biotech executives from around the world to gather strategic information and network amongst each other to facilitate new investment and foster new partnerships in China.

Over 65 presentations from companies including: Amgen, AstraZeneca, Bayer Schering Pharma, Boston Consulting Group, Bristol-Myers Squibb, Burrill & Co., Chipscreen Biosciences, Fidelity Investments, Goldman Sachs, Janssen China, Merck, Novartis, Novo Nordisk, Onyx Pharmaceuticals, Pfizer, RHEI Pharmaceuticals, and many more. For the full program, please visit the conference website at www.srinstitute.com/china.

An international audience consisting of hundreds of senior-level pharma and biotech executives from the business development, strategic planning, clinical development, global sourcing, and drug R&D functions will be in attendance.

For more information on China-based company registration or sponsorship/exhibition opportunities, please contact the organizer, Jon E. Liong of Strategic Research Institute at jliong@srinstitute.com or call (212)967-0095 ext. 243.

The Strategic Research Institute is part of ALM's Conference and Trade Show Division, one of North America's largest producers of educational and networking events for business leaders and the legal profession. The division offers more than 300 conferences and two leading industry tradeshows annually, on a broad range of topics.

ALM is a leading integrated media company, focused on the legal, real estate and business communities. ALM currently publishes 33 national and regional magazines and newspapers. Other ALM businesses include online, book and newsletter publishing, market research and content distribution. More information on ALM is available at www.alm.com.

Source: Business Wire

More News in this Category